ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

Lombardi Center Officials Say New Partnership To Provide For Expansion In Services, Patients.

February 23, 2001

Drug Development Effort Criticized

April 18, 1975

Bass & Howes Bought By DDB Seattle

March 22, 2002

NTP Board Approves Four New Concepts

October 8, 1982

Eppley Contract Renewed; To Be Recompeted

January 20, 1978

Clinical Trials: NCI Issues Clinical Alert On Chemo For Cervical Cancer

February 26, 1999